| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |